Johnson & Johnson (JNJ) : Analyst Rating Update

Johnson & Johnson (JNJ) : 6 brokerage houses believe that Johnson & Johnson (JNJ) is a Strong Buy at current levels. 2 Analyst considers the fundamentals to be worthy of a Buy recommendation. 8 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Johnson & Johnson (JNJ). Zacks Investment Research suggests a Buy with a rank of 2. 1 others believe that the stock has run up ahead of its fundamentals and advise a Strong Sell on the stock.The median of all the 17 Wall Street Analysts endorse the stock as a Buy with a rating of 2.29.

Johnson & Johnson (JNJ) : Currently there are 12 street experts covering Johnson & Johnson (JNJ) stock. The most bullish and bearish price target for the stock is $125 and $93 respectively for the short term. The average price target of all the analysts comes to $116.17. The estimated standard deviation from the target is $9.61.

Johnson & Johnson (NYSE:JNJ): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $121.93 and $121.54 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $122.66. The buying momentum continued till the end and the stock did not give up its gains. It closed at $122.64, notching a gain of 0.30% for the day. The total traded volume was 9,332,366 . The stock had closed at $122.27 on the previous day.

Also, Equity Analysts at the Brokerage Firm, Jefferies, maintains their rating on the shares of Johnson & Johnson (NYSE:JNJ). Jefferies has a Hold rating on the shares. As per the latest research report, the brokerage house raises the price target to $109 per share from a prior target of $108. The rating by the firm was issued on June 14, 2016. The company shares have rallied 25.06% from its 1 Year high price. On Jul 5, 2016, the shares registered one year high at $123.23 and the one year low was seen on Aug 24, 2015. The 50-Day Moving Average price is $115.79 and the 200 Day Moving Average price is recorded at $108.57.

Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Companys primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Companys subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Companys research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.